Immunosuppressive Agents: Recent Developments in Molecular Action and Clinical Application
- 1 June 1998
- journal article
- review article
- Published by Elsevier in Transplantation Proceedings
- Vol. 30 (4) , 1573-1579
- https://doi.org/10.1016/s0041-1345(98)00361-3
Abstract
No abstract availableThis publication has 69 references indexed in Scilit:
- Mechanism of action of the immunosuppressant rapamycinPublished by Elsevier ,1999
- New Immunosuppressive Drugs in Organ TransplantationThe Journal of Clinical Pharmacology, 1996
- REGULATION OF B CELL FUNCTION BY THE IMMUNOSUPPRESSIVE AGENT LEFLUNOMIDE1Transplantation, 1996
- Potential Applications of Therapeutic Drug Monitoring of Sirolimus Immunosuppression in Clinical Renal TransplantationTherapeutic Drug Monitoring, 1995
- Dihydroorotate Dehydrogenase Is a High Affinity Binding Protein for A77 1726 and Mediator of a Range of Biological Effects of the Immunomodulatory CompoundJournal of Biological Chemistry, 1995
- CALCINEURIN ACTIVITY IS ONLY PARTIALLY INHIBITED IN LEUKOCYTES OF CYCLOSPORINE-TREATED PATIENTSTransplantation, 1995
- PRECLINICAL EVALUATION OF A NEW POTENT IMMUNOSUPPRESSIVE AGENT, RAPAMYCINTransplantation, 1991
- Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejectionInflammation Research, 1991
- Cyclosporine Concentration Determinations for Monitoring and Pharmacokinetic StudiesThe Journal of Clinical Pharmacology, 1986
- Immunopharmacological profile of HWA 486, a novel isoxazol derivative— II. In vivo immunomodulating effects differ from those of cyclophosphamide, prednisolone, or cyclosporin AInternational Journal of Immunopharmacology, 1986